任意団体JBCRG論文・出版
2005年
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer.
Katsumasa Kuroi, Masakazu Toi, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama; Japan Breast Cancer Research Group (JBCRG)
Biomedicine and Pharmacotherapy. 2005 Oct; 59 Suppl 2: S387-392.
https://doi.org/10.1016/S0753-3322(05)80085-X
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer
Shinji Ohno, Masakazu Toi, Katsumasa Kuroi, Seigo Nakamura, Hiroji Iwata, Kusama M, Norikazu Masuda, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Shin E, Kaise H, Kurozumi M, Hitoshi Tsuda, Futoshi Akiyama; Japan Breast Cancer Research Group (JBCRG)
Biomedicine and Pharmacotherapy. 2005 Oct; 59 Suppl 2: S323-324.
https://doi.org/10.1016/s0753-3322(05)80063-0
Interim analysis of a phaseII trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breastcarcinoma
Hiroji Iwata, Seigo Nakamura, Masakazu Toi, Shin E, Norikazu Masuda, Shinji Ohno, Takatsuka Y,Hisamatsu K, Yamazaki K, Kusama M, Kaise H, Sato Y, Katsumasa Kuroi, Futoshi Akiyama, Hitoshi Tsuda, Masafumi Kurosumi; Japan Breast Cancer Research Group (JBCRG)
Breast Cancer. 2005; 12(2): 99-103.
https://doi.org/10.2325/jbcs.12.99